On Friday, WPX Energy Inc (NYSE:WPX)’s shares inclined 9.36% to $7.36.
WPX Energy’s (WPX) board of directors has approved a quarterly dividend of $0.85938 per share to holders of the company’s 6.25 percent Series A Mandatory Convertible Preferred Stock.
The dividend is payable on Nov. 2, 2015, to holders of record of the company’s preferred stock at the close of business on Oct. 15, 2015.
WPX Energy, Inc., an independent natural gas and oil exploration and production company, engages in the exploitation and development of unconventional properties in the United States. The company focuses on exploiting natural gas reserves base and related natural gas liquids in the Piceance Basin of the Rocky Mountain region, in addition to developing and growing oil positions in the Williston Basin in North Dakota and the San Juan Basin in the southwestern United States.
E I Du Pont De Nemours And Co (NYSE:DD)’s shares gained 1.88% to $49.26.
Tessenderlo Kerley, Inc. (TKI), a U.S. partner of Tessenderlo Group, and DuPont Crop Protection declared the sale of certain of DuPont’s global Hexazinone solo product and its Hexazinone/Diuron-only mixture product business assets to TKI. The sale excludes assets in Brazil. Financial terms of the agreement were not revealed.
The assets to be divested by DuPont comprise the Velpar®, Pronone® and Advance® trademarks, formulated product registrations, formulated product registration data, customer information, supply agreements with third parties, access to certain know-how, certain Hexazinone and Diuron technical registrations and associated registration data, for each product.
Hexazinone is a broad spectrum herbicide used on crops such as alfalfa, blueberries, pineapples and sugarcane and is marketed globally under the Velpar®, Pronone® and Advance® brands.
E I. du Pont de Nemours and Company operates as a science and technology based company worldwide. The company’s Agriculture segment offers corn hybrid, soybean, canola, sunflower, sorghum, inoculants, seed products, wheat, rice, herbicides, fungicides, and insecticides.
At the end of Friday’s trade, Sequenom, Inc. (NASDAQ:SQNM)‘s shares surged 2.40% to $2.13.
Sequenom, Inc. (SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, provides its current revenue outlook for the second half of 2015.
The Company is updating its revenue expectations for the second half of the year to a range between $57 million and $61 million, bringing 2015 annual revenue expectations to a range between $127 million and $131 million.
Drivers for the updated expectations comprise raised competition and price compression in the noninvasive prenatal testing (NIPT) market.
The Company anticipates to declare its financial results for the third quarter on November 4, 2015, and will provide further discussion of its operating results at that time.
Sequenom, Inc., a life sciences company, develops and commercializes molecular diagnostics testing services for the women’s health and oncology markets in the United States and internationally.
Banco Bradesco SA (ADR) (NYSE:BBD), ended its Friday’s trading session with 4.52% gain, and closed at $5.65.
Shares of Banco Bradesco SA (NYSE:BBD) have received an average recommendation of “Hold” from the seven research firms that are covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $9.00.
Banco Bradesco S.A. provides banking and financial products and services to individuals, companies, and corporations and institutions. The company operates through two segments, Banking; and Insurance, Pension Plans and Capitalization Bond. It accepts various deposit products, such as demand deposits, time deposits, checking accounts, savings accounts, interbank deposits from financial institutions, and accounts for salary purposes.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
